FDA drug reviewers questioned a Genzyme study meant to back wider use of the company's Clolar leukemia drug, according to documents released ahead of an advisory panel review. Report
What could you do with real-time supply chain information at your fingertips?
Interested in complete supply chain real-time data visibility? Unlock productivity with digital workflows, manage plants inventory with real-time supply chain information and enable faster decision-making with data visualization with pci | bridge. Register today!